Schizophrenia News

Tocilizumab may be a potential adjunctive treatment for cognitive impairment in individuals with schizophrenia, according to recent findings.

Recent findings indicated nonrandom mating within specific psychiatric disorders and across the spectrum of psychiatric disorders.

Risk for attempted suicide was six times higher among noninstitutionalized individuals with schizophrenia compared with those without the disorder, according to recent findings.

Recent findings indicated overall psychopathology was associated with both abnormal patterns of activation and failure to activate executive regions in youth with various psychiatric disorders.

Schizophrenia polygenic risk scores indicated broad negative symptoms but not isolated psychotic symptoms, according to recent findings.

Otsuka Pharmaceutical Co. Ltd, and Lundbeck recently announced the FDA accepted for review a supplemental New Drug Application for Rexulti for maintenance treatment of schizophrenia in adults.

As the New Year begins to pick up speed, Healio.com/Psychiatry took a moment to reflect on the most popular psychiatry news stories published in January 2016.

A meta-analysis found insufficient evidence on what antipsychotic is most effective for individuals with treatment-resistant schizophrenia, indicating a need for improved research.

Versions of a gene associated with schizophrenia may prompt synaptic pruning during adolescence, according to recent findings from an NIH-funded study.

Coordinated specialty care was more cost-effective than typical community care for young individuals with first-episode psychosis, according to findings from the Recovery After an Initial Schizophrenia Episode (RAISE) initiative.